Alkermes (ALKS) Return on Capital Employed (QoQ) (2012 - 2026)
Alkermes (ALKS) Return on Capital Employed (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn |
| 3 | Zoetis | 31.67 Bn | 29.99 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.23 Bn | 19.57 Bn | 683.80 Mn |
| 6 | Viatris | 18.70 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -372.00 |
| Mar 31, 2026 | -670.00 |
| Dec 31, 2025 | -612.00 |
| Sep 30, 2025 | -279.00 |
| Jun 30, 2025 | -154.00 |
| Mar 31, 2025 | -158.00 |
| Dec 31, 2024 | 755.00 |
| Sep 30, 2024 | 9.00 |
| Jun 30, 2024 | -1,003.00 |
| Mar 31, 2024 | 349.00 |
| Dec 31, 2023 | -292.00 |
| Sep 30, 2023 | 671.00 |
| Jun 30, 2023 | 2,009.00 |
| Mar 31, 2023 | 108.00 |
| Dec 31, 2022 | -94.00 |
| Sep 30, 2022 | -266.00 |
| Jun 30, 2022 | -251.00 |
| Mar 31, 2022 | -66.00 |
| Dec 31, 2021 | 1,048.00 |
| Sep 30, 2021 | -62.00 |